APP and Alzheimer disease: The presence of mutations in APP or PSEN1/2 in familiar AD initially supported the hypothesis of the “Amyloid cascade” as a central player in AD onset and progression, indicating the over-production of Aβ as the causative event responsible for the pathophysiological process leading to AD progression.